Signature scores were greater in tumors having non-silent TSC1 or TSC2 mutations versus other bladder tumors (Figure 4E) indicating that these cancers have an identifiable gene expression signature derived from inactivation of TSC1 or TSC2. The gene discussed is TSC2; the disease is urinary bladder neoplasm.